Abstract
Phase 1b Study of Pembrolizumab in Patients with Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma: Results from the Ongoing Keynote-013 Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have